Lode Debrabandere
2013
In 2013, Lode Debrabandere earned a total compensation of $506.8K as President and CEO at Osiris Therapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $120,000 |
| Salary | $316,750 |
| Other | $20,000 |
| Total | $506,750 |
Debrabandere received $316.8K in salary, accounting for 63% of the total pay in 2013.
Debrabandere also received $50K in bonus, $120K in option awards and $20K in other compensation.
Rankings
In 2013, Lode Debrabandere's compensation ranked 9,311th out of 12,286 executives tracked by ExecPay. In other words, Debrabandere earned more than 24.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,311 out of 12,286 | 24th |
Division Manufacturing | 3,412 out of 4,612 | 26th |
Major group Chemicals And Allied Products | 1,081 out of 1,462 | 26th |
Industry group Drugs | 831 out of 1,156 | 28th |
Industry Biological Products, Except Diagnostic Substances | 138 out of 196 | 30th |
Source: SEC filing on April 30, 2015.
Debrabandere's colleagues
We found three more compensation records of executives who worked with Lode Debrabandere at Osiris Therapeutics in 2013.